PK / PD, Pharmacology, and GT Strategy
Sources covering [PK] / [PHARMACOLOGY] dose-PK-PD-efficacy relationships, translational modelling, binding affinity, [GT] AAV / capsid / promoter / dose scaling, PET ligand parameters / dose / Steering Committee workflow, ICM / route of administration / peripheral leak, and life-cycle / study population framing.
Source-of-truth pages live in data/processed/markdown/by-photo/. Each row below points first to the KB source note (which carries the heading list) and then to the canonical transcription.
Sources in this section: 11
Top-level nav clusters: 10
[PK]
2 source pages
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_184716 | Page 1229 of 1238 | [PK] > Parameters > Dose-PK-PD-Efficacy relationship in Vivo | note | md |
20240722_184720 | Page 1229 of 1239 | [PK] > Parameters > Dose-PK-PD-Efficacy relationship > Translational modeling (and prediction of clinical efficacy) using a ref… | note | md |
[GT] > AAV > Clinical trial / Dose Selection (visible page spans multiple headings)
1 source page
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_184746 | Page 1260 of 1270 | [GT] > AAV > Clinical trial / Dose Selection (visible page spans multiple headings) | note | md |
[PHARMACOLOGY]
1 source page
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_184806 | Page 1276 of 1287 | [PHARMACOLOGY] > Binding Affinity > PK-PD relationship | note | md |
Life-cycle
1 source page
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_184749 | Page 1260 of 1271 | Life-cycle > Localization > Manufacturing > PK/PD strategy | note | md |
Measurement of OS
1 source page
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_184443 | Page 1075 of 1085 | Measurement of OS > Route of Administration > ICM (= Suboccipital puncture) > Peripheral leak/transduction | note | md |
PK/PD
1 source page
PK/PD strategy
1 source page
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_184753 | Page 1264 of 1277 | PK/PD strategy > Dose Scaling for GT > Promoter | note | md |
Study population
1 source page
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_184759 | Page 1273 of 1282 | Study population > Type of gene therapy > Units (dose and transgene expression) > [PHARMACOLOGY] | note | md |
Units (dose and transgene…)
1 source page
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_184802 | Page 1273 of 1284 | Units (dose and transgene…) > [PHARMACOLOGY] > Binding Affinity > PK-PD relationship | note | md |
Workflow
1 source page
| photo | page | nav path | source note | transcription |
|---|---|---|---|---|
20240722_184833 | Page 1304 of 1314 | Workflow > Budget/Responsibilities | note | md |